Summary for Tradename: ZAVESCA
Clinical Trials for: ZAVESCA
A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated Reaction
Status: Not yet recruiting Condition: Pompe Disease; Hypersensitivity Reaction
Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
Status: Active, not recruiting Condition: Gangliosidoses GM2
Miglustat in Niemann-Pick Type C Disease
Status: Completed Condition: Niemann-Pick Type C Disease
Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
Status: Terminated Condition: Cystic Fibrosis
Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®
Status: Active, not recruiting Condition: Diarrhea
Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
Status: Completed Condition: GM2 Gangliosidoses; Tay-Sachs; Sandhoff Disease
Application of Miglustat in Patients With Niemann-Pick Type C
Status: Completed Condition: Niemann-Pick Disease Type C
Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease
Status: Completed Condition: Type 1 Gaucher Disease
Synergistic Enteral Regimen for Treatment of the Gangliosidoses
Status: Recruiting Condition: GM1 Gangliosidoses; GM2 Gangliosidoses; Tay-Sachs Disease; Sandhoff Disease
Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?
Status: Completed Condition: Cystic Fibrosis
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
Actelion Pharms Ltd
|CAPSULE;ORAL||021348||Jul 31, 2003||RX||Yes||<disabled>||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639